|
|
Progress in the Study on Biocompatibility of Absorbable Hemostatic Materials |
1 Department of Pharmacy,Guangzhou General Hospital of Guangzhou Military Command of PLA,Guangzhou 510010,China
2 Guangdong Pharmaceutical University,Guangzhou 510006,China
3 Graduate School, Southern Medical University,Guangzhou 510515,China |
|
|
Abstract Absorbable hemostatic materials are one of biomedical materials that applied to stanch bleeding. They are degradable in vivo and play an important role in the surgical hemostasis. In recent years, absorbable haemostatic materials mainly include chitosan, fibrinogen, cyanoacrylates, oxidized cellulose, collagen. Except for hemostatic effect, the biocompatibility is also an important feature for the quality of these materials. In this article, we made a comprehensive evaluation among the absorbable hemostatic materials under the guidance of safety and efficacy of biocompatibility, aiming to provide a valuable reference for the utility and development of absorbable hemostatic materials in further research.
|
|
|
|
|
[1]杨晓芳,奚廷斐.生物材料生物相容性评价研究进展[J].生物医学工程学杂志,2001,18(1):123-128.
[2]张世庆,赵雄,鲁景艳,等.可吸收止血材料研究现状与相关技术要求[J].军事医学,2012,36(11):862-866.
[3]Gu BK, Park SJ, Kim MS, et al. Gelatin blending and sonication of chitosan nanofiber mats produce synergistic effects on hemostatic functions[J]. Int J Biol Macromol, 6 Oct,2015[Epub ahead of print].
[4]宋来福,邵凯,刘万顺,等.壳聚糖即型水凝胶的理化性质、止血功能和生物相容性研究[J].功能材料,2014,45(9):9065-9069.
[5]李若慧,张雪,单丹彤,等.壳聚糖的生物相容性[J].中国组织工程研究,2012,16(12):2237-2240.
[6]孟晓荣,王琼,赵亮,等. 壳聚糖/PHB/PEG多元共混膜的制备与体外血液相容性研究[J].功能材料,2010,
41(12):2198-2202.
[7]郭苗苗,浦金辉,徐丹,等.壳聚糖基快速止血材料的研究进展[J].中国医院药学杂志,2012,32(1):49-51.
[8]Zhang Zhe, Cui Huifei. Biodegradability and biocompatibility study of poly (Chitosanglactic Acid) scaffolds[J].Molecules,2012,17(3):3243-3258.
[9]田昆仑,刘良明,范小青,等.异丁基壳聚糖多功能创面敷料的生物学效应[J].中国临床康复,2005, 9(38):33-35.
[10]姜毅,王风华,段蕴铀. 多糖类止血材料的研究及应用进展[J].解放军医学杂志,2014,39(12):1004-1007.
[11]马茂,范代娣.壳聚糖-类人胶原蛋白对兔肝创面的止血效果及组织相容性观察[J].第四军医大学学报,2007,28(12):1122-1124.
[12]Alfars A, Khashjoori BK.Evaluation of effectiveness of chitosan hydrogel as haemostatic from dorsal nasal veins in rabbits[J]. Bas J Vet Res,2008,7(1):19-25.
[13]Wang Xiaohong, Yan Yongnian, Zhang Renji. A comparison of chitosan and collagen sponges as hemostatic dressings[J].Journal of Bioactive and Compatible Polymers,2006,21(1): 39-54.
[14]薛燕.组织粘合剂在伤口中的应用[J].中国医疗器械信息,2012,18(2):7-12.
[15]Lins RDAU, Gomes RCB, Santos KSM, et al. Use of cyanoacrylate in the coaptation of edges of surgical wounds[J]. An Bras Dermatol, 2012,87(6):871-876.
[16]Toriumi DM, Baqal AA. Cyanoacrylate tissue adhesives for skin closure in the outpatient setting[J].Otolarynqol Clin North Am, 2002,35(1):103-18.
[17]Montanaro L, Arciola CR, Cenni E. Cytotoxicity, blood compatibility and antimicrobial activity of two cyanoacrylate glues for surgical use[J]. Biomaterials, 2001,22(1):59-66.[18]Barreno AC, Vergiú CC, Malatto JR. Biocompatibility of nbutylcyanoacrylate compared to conventional skin sutures in skin wounds[J]. Revista Odontológica Mexicana, 2013, 17 (2): 81-89.
[19]Lee YJ, Jung GB, Cho SJ, et al. Biocompatibility of a novel cyanoacrylate based tissue adhesive: cytotoxicity and biochemical property evaluation[J].PLoS ONE,2013,8(11):1-9.
[20]蔡大振,徐亮,孟庆国,等. α\|氰基丙烯酸酯类医用黏合剂的研究进展[J].军事医学,2012,36(3):238-241.
[21]Bae KB, Kim SH, Jung SJ, et al. Cyanoacrylate for colonic anastomosis: is it safe?[J]. Int J Colorect Dis,2010,
25(5):601-606.
[22]宋强,肖世维,但年华,等.胶原在止血材料中的应用[J].西部皮革,2013,35(4):8-14.
[23]Farndale RW, Sixma JJ, Barnes MJ, Groot PG. The role of collagen in thrombosis and hemostasis[J].Thrombosis and Haemostasis, 2004, 2:561-573.
[24]刘新华,但年华,李正军,等.胶原基复合医用海绵的研究进展[J].西部皮革,2012,34(8):13-17.
[25]Parenteau\|Bareil R, Gauvin R, Berthod F.CollagenBased biomaterials for tissue engineering applications [J].Material,2010,3:1863-1887.
[26]Soo C, Trahbar G, Moy RL. The immunogenicity of bovine collagen implants[J]. I Dermatol Surg Oncol, 1993,
19(5):431- 434.
[27]冯玉萍,马忠仁,乔自林.新生牛跟腱胶原蛋白海绵与细胞的生物相容性[J].中国组织工程研究与临床康复,2007,11(1):70-73.
[28]迟妍妍,乐尧金,刘旭超,等. 胶原蛋白海绵的生物特性及体内降解吸收[J].中国组织工程研究,2014,18(34):5515-5519.
[29]Duan Zhiguang,Fan Daidi,Zhu Chenhui. Hemostatic efficacy of humanlike collagen sponge in arterioles and liver injury model[J]. African Journal of Microbiology Research, 2012,6(10): 2543-2551.
[30]Hermans MHE, Brown L, Darmoc M. Adhesion prevention in an intraperitoneal wound model: Performance of two resorbable hemostats in a controlled study in rabbits[J]. J Biomed Mater Res B Appl Biomater, 2012, 100(6): 1621-1626.
[31]Antonio F, Guillem R, Sonia T, et al. Cross\|linked collagen sponges loaded with plant polyphenols with inhibitory activity towards chronic wound enzymes[J]. Biotechnol J, 2011, 6(10): 1208-1218.
[32]Kim YW, Kang MJ, Lee HJ,et al. The efficacy of TachoComb on reducing postoperative complications after tonsillectomy in children[J]. Int J Pediatr Otorhinolaryngol, 2015,79(8):1337-1340.
[33]Ramasamy P, Shanmugam A. Characterization and wound healing property of collagenchitosan film from Sepia kobiensis (Hoyle, 1885)[J]. Int J of Biol Macromol, 2015, 74: 93-102
[34]Li B, Liu X, Cao C, et al. Biocompatibility and antibacterial activity of plasma sprayed titania coating grafting collagen and gentamicin[J]. J Biomed Mater Res, 2007, 83〖STBZ〗(4): 923-930.
[35]Matthews J A, Wnek G E, Simpson D G, et al. Electrospinning of collagen nanofibers[J]. Biomacromolecules, 2002, 3(2): 232-238.
[36]Dickneite G, Metzner HJ, Kroez M, et al. The importance of factor Ⅷ as a component of fibrin sealants[J]. J Surg Res, 2002,107(2):186-195.
[37]Kram HB, Hino ST, Harley DP, et al. Use of concentrated fibrinogen in experimental splenic trauma[J]. J Biomed Mater Res, 1986 20(5):547-553.
[38]Kjaergard H.K., Axelsen P. Effectiveness of autologous fibrin sealant in experimental lung surgery[J]. Eur Surg Res, 1996,28(2):162-166.
[39]苏怡,候延文,高珉之.医用生物蛋白胶生物性能的研究[J].预防医学情报杂志,2001,17(6):433-435.
[40]王春仁,王召旭,宋谊萍,等.医用纤维蛋白胶亚急性毒性实验研究[J].中国药事,2007,21(7):472-474.
[41]蔡阳,任真,何学军,等.纤维蛋白黏合剂免疫原性的研究[J].免疫学杂志,2011,27(9):769-772.
[42]Nichols W. Adverse antibodymediated reactions to topical bovine thrombin and fibrin glue[C] // Nichols W Symposium on Fibrin Sealant: Characteristics and Clinical Use. Bethesda: Uniformed Services University of the Health Sciences, 1994: 5-10.
[43]TomizawaY. Clinical benefits and risk an alysis of topical hemostats:a review[J].J Artif Organs,2005,8(3):137
[44]王丽,相秉仁,邹巧根.氧化纤维素的制备及结构和性能的研究[J].药学进展2009,33(8):365-369.
[45]Kakaei F, Seyyed Sadeghi MS, Sanei B, et al. A randomized clinical trial comparing the effect of different haemostatic agents for haemostasis of the liver after hepatic resection[J]. HPB Surgery, 2013, 2013:1-5.
[46]Ibrahim MF, Aps C, Young CP.A foreign body reaction to Surgicel mimicking an abscess following cardiac surgery[J]. Eur J Cardiothorac Surg,2002,22(3):489\|490.
[47]李明洋,黄赤兵,范明齐,等.负压吸附式止血敷贴的制备及生物相容性[J].中国组织工程研究与临床康复,2011,15(47):8813-8816.
[48]姜丽娟,李玲,张春霞,等.可吸收多糖微球的制备及生物相容性研究[J].生物医学工程研究,2014,33〖STBZ〗(1):32-34.
[49]Nunamaker E A, Purcell E K, Kipke D R. In vivo stability and biocompatibility of implanted calcium alginate disks[J]. J Biomed Mater Res A, 2007, 83(4): 1128-1137.
[50]Lai J Y. Biocompatibility of chemically crosslinked gelatin hydrogels for ophthalmic use[J]. J Mater Sci Med, 2010, 21(6): 1899-1911.
|
|
|
|